Journal of Emergencies, Trauma, and Shock
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
Users online:379   Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size   


 
LETTER TO EDITOR Table of Contents   
Year : 2010  |  Volume : 3  |  Issue : 3  |  Page : 308
Commenting on biomarkers for differentiating between SIRS and sepsis


Wiwanitkit House, Bangkhae, Bangkok - 101 60, Thailand

Click here for correspondence address and email

Date of Web Publication19-Jul-2010
 

How to cite this article:
Wiwanitkit V. Commenting on biomarkers for differentiating between SIRS and sepsis. J Emerg Trauma Shock 2010;3:308

How to cite this URL:
Wiwanitkit V. Commenting on biomarkers for differentiating between SIRS and sepsis. J Emerg Trauma Shock [serial online] 2010 [cited 2019 Jun 18];3:308. Available from: http://www.onlinejets.org/text.asp?2010/3/3/308/66554


Sir,

I read the recent report on new biormarkers for differentiating between systemic inflammatory response syndrome (SIRS) and sepsis with great interest. [1] Indeed, at present, there are many new biomarkers that might be useful in the clinical management of cases suspected for sepsis. [2] Punyadeera et al. reported that metalloproteinases and selectin play a role in the distinction between SIRS and sepsis, and that IL-1α, IP-10, sTNF-R2 and sFas appear to be indicative for the progression from sepsis to septic shock.[1] Based on laboratory medicine principle, there are some comments on this work. First, as Punyadeera et al. mentioned that their results were only preliminary data, the main flaw of this work is the very few numbers of subjects studied. Second, there can be several factors that affect the level of studied parameters. Several parameters are classified as respondents to inflammation and there is no data whether there is any concomitant inflammation in the studied subjects. In addition, in sepsis, the causative agents are still questionable. Whether different causative agents for sepsis result in different levels of studied parameters needs to be clarified. Finally, as noted by Herzum and Renz, international definition and staging criteria have to be internationally agreed and set to be used in the interpretation of the laboratory parameters in real clinical practice. [3]

 
   References Top

1.Punyadeera C, Schneider EM, Schaffer D, Hsu H, Joos TO, Kriebel F, et al. A biomarker panel to discriminate between SIRS and sepsis and sepsis severity. J Emerg Trauma Shock 2010;3:26-35.  Back to cited text no. 1  [PUBMED]  Medknow Journal  
2.Ventetuolo CE, Levy MM. Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med 2008;29:591-603.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Herzum I, Renz H. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 2008;15:581-7.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  

Top
Correspondence Address:
Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok - 101 60
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2700.66554

Rights and Permissions




 

Top
 
  Search
 
  
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1950    
    Printed87    
    Emailed0    
    PDF Downloaded32    
    Comments [Add]    

Recommend this journal